Ondrey Aaron — SEC insider filings
SEC reporting owner CIK 1991078. 9 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2023-09-12 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 8,966 shares, $43,903 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 7,489 shares @ $5.29 ($39,647) in ROCKET PHARMACEUTICALS, INC., filed 2025-04-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | Chief Financial Officer | 4 | — | 2 legs · 8,966 sh · $43,903 | 4 |
| Mirati Therapeutics, Inc. (MRTX) | Chief Financial Officer | 3 | — | — | 8 |
| Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 2 | — | — | 1 |
Insider filings — Ondrey Aaron
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 3 | Syndax Pharmaceuticals Inc (SNDX) | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 270,000 (derivative) @ $9.55 | EDGAR |
| 2025-07-08 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,477 @ $2.88 | EDGAR |
| 2025-04-08 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 7,489 @ $5.29 | EDGAR |
| 2025-02-13 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 90,358 @ $0 · Grant/award (A): 134,642 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 46,781 @ $0 · Grant/award (A): 69,337 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Mirati Therapeutics, Inc. (MRTX) | Disposition to issuer (D): 1,302 · Disposition to issuer (D): 21,138 · Disposition to issuer (D): 17,021 · Disposition to issuer (D): 6,817 (derivative) · Disposition to issuer (D): 5,027 (derivative) · Disposition to issuer (D): 11,993 (derivative) | EDGAR |
| 2024-01-03 | 4 | Mirati Therapeutics, Inc. (MRTX) | Grant/award (A): 17,021 @ $58.75 | EDGAR |
| 2023-09-12 | 4 | Mirati Therapeutics, Inc. (MRTX) | Grant/award (A): 8,412 @ $35.66 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991078 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs